Kangdong Liu Selected Research

Kangdong Liu Research Topics

Disease

122	Neoplasms (Cancer) 04/2024 - 06/2009
47	Esophageal Squamous Cell Carcinoma 04/2024 - 12/2012
25	Carcinogenesis 04/2024 - 06/2009
16	Esophageal Neoplasms (Esophageal Cancer) 12/2022 - 12/2012
15	Lung Neoplasms (Lung Cancer) 12/2023 - 05/2015
13	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 02/2015
11	Stomach Neoplasms (Stomach Cancer) 05/2023 - 06/2018
10	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2016
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 10/2014
7	Inflammation (Inflammations) 01/2024 - 09/2016
6	Colonic Neoplasms (Colon Cancer) 04/2024 - 06/2011
5	Melanoma (Melanoma, Malignant) 01/2023 - 05/2011
5	Infections 01/2022 - 02/2008
5	Skin Neoplasms (Skin Cancer) 01/2021 - 02/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2012
4	Carcinoma (Carcinomatosis) 11/2018 - 12/2014
4	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2011
3	COVID-19 10/2022 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2020
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 01/2021
2	Esophagitis 01/2022 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 05/2020
2	Mouth Neoplasms (Oral Cancer) 07/2021 - 05/2018
2	Genomic Instability 01/2021 - 01/2021
2	Bone Resorption 01/2021 - 12/2016
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2009
2	Triple Negative Breast Neoplasms 09/2019 - 06/2017
2	Neoplastic Cell Transformation 12/2018 - 01/2011
2	Squamous Cell Carcinoma of Head and Neck 05/2018 - 04/2016

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2009
18	Phosphotransferases (Kinase)IBA 12/2023 - 11/2009
8	Gefitinib (Iressa)FDA Link 08/2023 - 10/2014
7	FlavonoidsIBA 01/2021 - 09/2013
6	Protein Kinases (Protein Kinase)IBA 02/2024 - 06/2011
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
6	AntioxidantsIBA 01/2023 - 04/2016
6	CateninsIBA 01/2022 - 05/2017
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 01/2020
5	Monoclonal AntibodiesIBA 06/2023 - 01/2020
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023 - 11/2011
5	EnzymesIBA 01/2023 - 07/2015
5	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2012
4	IntegrinsIBA 07/2023 - 10/2011
4	AntigensIBA 01/2023 - 06/2017
4	Aurora Kinase AIBA 01/2022 - 03/2019
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2018
4	aloe emodinIBA 12/2018 - 07/2012
3	Messenger RNA (mRNA)IBA 04/2024 - 11/2017
3	Nucleotide AptamersIBA 01/2024 - 06/2021
3	ProteomeIBA 01/2023 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2019
3	CytokinesIBA 01/2022 - 01/2020
3	CarcinogensIBA 01/2022 - 11/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021 - 05/2018
3	Therapeutic UsesIBA 04/2021 - 05/2016
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 09/2013
3	p21-Activated KinasesIBA 01/2021 - 01/2020
3	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2020 - 07/2015
3	Small Interfering RNA (siRNA)IBA 02/2018 - 06/2009
2	artenimol (dihydroartemisinin)IBA 12/2023 - 01/2020
2	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 12/2023 - 06/2016
2	ErianinIBA 12/2023 - 01/2023
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2023 - 12/2019
2	PerforinIBA 01/2023 - 01/2021
2	N- (12- cyanoindolizino(2,3- b)quinoxalin- 2- yl)thiophene- 2- carboxamideIBA 01/2023 - 12/2019
2	Granzymes (Granzyme)IBA 01/2023 - 01/2021
2	sulphorapheneIBA 01/2023 - 01/2019
2	MitogensIBA 01/2023 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 12/2022 - 06/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 01/2022
2	acetylshikoninIBA 10/2022 - 01/2020
2	costunolideIBA 10/2022 - 07/2021
2	tegaserod (Zelnorm)FDA Link 07/2022 - 01/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 05/2018
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2019
2	Eflornithine (Ornidyl)FDA Link 01/2022 - 01/2017
2	ubenimexIBA 11/2021 - 06/2019
2	IsoflavonesIBA 01/2021 - 05/2017
2	Caspase 3 (Caspase-3)IBA 10/2020 - 12/2019
2	xanthohumolIBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2016
2	CaspasesIBA 01/2020 - 05/2018
2	Antimalarials (Antimalarial Agents)IBA 01/2020 - 01/2020
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 09/2016
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2020 - 11/2018
2	Annexin A5IBA 01/2020 - 01/2020
2	NF-kappa B (NF-kB)IBA 09/2019 - 01/2019
2	polypeptide 3 90kDa ribosomal protein S6 kinaseIBA 09/2019 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 06/2011
2	VaccinesIBA 11/2018 - 10/2016
2	eupatilinIBA 06/2018 - 09/2016
2	oridoninIBA 05/2018 - 01/2018

Therapy/Procedure

33	Therapeutics 04/2024 - 06/2009
12	Chemoprevention 05/2023 - 02/2012
7	Drug Therapy (Chemotherapy) 01/2024 - 01/2014
5	Immunotherapy 04/2024 - 01/2019
3	Oral Administration 11/2021 - 09/2018
2	Radiotherapy 01/2023 - 05/2021
2	Aftercare (After-Treatment) 01/2022 - 01/2020